Insulin Resistance: When a provider prescribes GLP-1 to treat insulin resistance or related metabolic issues, it may qualify for HSA and FSA coverage
Even if you lose 15% of your overall body weight, this is 12% higher than those who used only diet and exercise, which will excite many who are struggling to lose weight
Unsurprisingly, such patients typically have a more guarded prognosis than age-matched, normal weight peers, since obesity is accompanied by an increased pregnancy loss rate
Feb 26, 2026 At the cellular level, semaglutide triggers a cascade of metabolic events that suppress appetite, slow gastric emptying, and improve insulin sensitivity
Clinical trials have demonstrated average weight loss of approximately 15% with semaglutide, 2022% with tirzepatide, and over 24% with retatrutide over the course of treatment